Pnc Financial Services Group, Inc. Atea Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 892 shares of AVIR stock, worth $2,845. This represents 0.0% of its overall portfolio holdings.
Number of Shares
892
Previous 49
1720.41%
Holding current value
$2,845
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$29.1 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24.3 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$15.3 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$15.1 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.93 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $266M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...